Medicure Inc. (CVE:MPH – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as C$0.88 and last traded at C$0.88, with a volume of 18500 shares changing hands. The stock had previously closed at C$0.88.
Medicure Price Performance
The firm has a 50-day moving average of C$0.96 and a 200 day moving average of C$1.03. The company has a market capitalization of C$9.19 million, a PE ratio of -3.52 and a beta of 0.90. The company has a debt-to-equity ratio of 2.06, a current ratio of 1.87 and a quick ratio of 1.29.
Medicure (CVE:MPH – Get Free Report) last released its quarterly earnings data on Wednesday, August 14th. The company reported C($0.12) earnings per share for the quarter. Medicure had a negative net margin of 12.56% and a negative return on equity of 12.90%. The company had revenue of C$5.17 million for the quarter. As a group, research analysts anticipate that Medicure Inc. will post 0.0652819 earnings per share for the current fiscal year.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- Pros And Cons Of Monthly Dividend Stocks
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- What is Short Interest? How to Use It
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Want to Profit on the Downtrend? Downtrends, Explained.
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
